Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry.

Eur J Gastroenterol Hepatol · 2021 · PMC7846287 · PMID 32345848

Europe PMC DOI

hedged sentence

0.2680

closest p · 5.4× alpha

0.2680

boldest claim

The sentences

a nonsignificant trendP = 0.268not close (p > 0.1)

There was a nonsignificant trend towards higher prevalence of renal dysfunction (4.5%, n = 4 vs. 9.3%, n = 10) ( P = 0.268), metabolic (4.5%, n = 4 vs. 10.3%, n = 11) ( P = 0.179) and psychiatric disorders (12.5%, n = 11 vs. 19.6%, n = 21) ( P = 0.244) in patients with high BVL.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.